Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains
- PMID: 12351421
- DOI: 10.1182/blood-2002-02-0428
Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains
Abstract
The T-cell receptor zeta (TCR-zeta) and FcR-gamma chains play a critical role in mediating signal transduction. We have previously described HIV glycoprotein 120 (gp120)-specific chimeric immune receptors (CIRs) in which the extracellular domain of CD4 is linked to the signaling domain of zeta (CD4zeta) or gamma (CD4gamma). Such CIRs are efficiently expressed following retroviral transduction of mature T cells and specifically redirect effector functions toward HIV-infected targets. In this report, we examine development of CD4zeta- or CD4gamma-expressing T cells from retrovirally transduced hematopoietic stem cells following bone marrow transplantation. Although CD4zeta/gamma-expressing myeloid, NK, and B cells were efficiently reconstituted, parallel development of CD4zeta/gamma-expressing T cells was blocked prior to the CD25(+)CD44(+) prothymocyte stage. In contrast, T cells expressing a signaling-defective CIR were efficiently generated. When major histocompatibility complex (MHC) class II-deficient mice were used as transplant recipients, development of CD4zeta/gamma-expressing T cells was restored. We conclude that CD4zeta/gamma signaling generated following engagement of MHC class II selectively arrests T-lineage development.
Similar articles
-
Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing zeta or gamma signaling domains.J Immunol. 1998 Jul 1;161(1):375-84. J Immunol. 1998. PMID: 9647246
-
Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes.J Immunol. 1995 Jul 15;155(2):1000-9. J Immunol. 1995. PMID: 7608531
-
Developmental arrest of NK1.1+ T cell antigen receptor (TCR)-alpha/beta+ T cells and expansion of NK1.1+ TCR-gamma/delta+ T cell development in CD3 zeta-deficient mice.J Exp Med. 1995 Sep 1;182(3):891-5. doi: 10.1084/jem.182.3.891. J Exp Med. 1995. PMID: 7650493 Free PMC article.
-
Fidelity and infidelity in commitment to B-lymphocyte lineage development.Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review.
-
Porcine T lymphocytes and NK cells--an update.Dev Comp Immunol. 2009 Mar;33(3):310-20. doi: 10.1016/j.dci.2008.06.003. Epub 2008 Jul 2. Dev Comp Immunol. 2009. PMID: 18601948 Review.
Cited by
-
HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells.Mol Ther. 2015 Aug;23(8):1358-1367. doi: 10.1038/mt.2015.102. Epub 2015 Jun 8. Mol Ther. 2015. PMID: 26050990 Free PMC article.
-
Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.Biochem Biophys Res Commun. 2015 Jul 31;463(3):216-21. doi: 10.1016/j.bbrc.2015.05.026. Epub 2015 May 19. Biochem Biophys Res Commun. 2015. PMID: 25998390 Free PMC article.
-
CARs: Beyond T Cells and T Cell-Derived Signaling Domains.Int J Mol Sci. 2020 May 15;21(10):3525. doi: 10.3390/ijms21103525. Int J Mol Sci. 2020. PMID: 32429316 Free PMC article. Review.
-
Stem cell-derived CAR T cells traffic to HIV reservoirs in macaques.JCI Insight. 2021 Jan 11;6(1):e141502. doi: 10.1172/jci.insight.141502. JCI Insight. 2021. PMID: 33427210 Free PMC article.
-
Hematopoietic stem cells for cancer immunotherapy.Immunol Rev. 2014 Jan;257(1):237-49. doi: 10.1111/imr.12128. Immunol Rev. 2014. PMID: 24329801 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous